The clinical response of vinorelbine and cisplatin regimen (NP) combined with TOR was observed in non-small cell lung cancer (NSCLC).

• 观察长春瑞滨-顺铂(NP)方案联合托瑞米芬(TOR)治疗56例晚期非小细胞肿癌的临床疗效。